Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza

Archives of Virology

Volumn 154, Issue 8, 2009, Pages 1203-1210

  Wu, Rui ^a,b   Chen, Quanjiao ^a   Zheng, Liyun ^a   Chen, Jianjun ^a   Sui, Zhiwei ^a   Guan, Yi ^c   Chen, Ze ^a,d,e  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d HUNAN NORMAL UNIVERSITY   (China)

^e SHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; AVES; AVIAN INFLUENZA VIRUS; ESCHERICHIA COLI; MUS; ORTHOMYXOVIRIDAE;

INFLUENZA VACCINE; SIALIDASE; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; AVIAN INFLUENZA; BAGG ALBINO MOUSE; BIRD; BLOOD; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ENGINEERING; GENETIC REASSORTMENT; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A H9N2; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; MOUSE; ORTHOMYXOVIRUS INFECTION; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; BIRDS; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ENGINEERING; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; REASSORTANT VIRUSES; VACCINATION;

EID: 70349569546     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-009-0425-6     Document Type: Article

References (32)

1. Alexander DJ (2007) An overview of the epidemiology of avian influenza. Vaccine 25:5637-5644.
2. Butt KM, Smith GJ, Chen H, Zhang LJ, Leung YH, Xu KM, Lim W, Webster RG, Yuen KY, Peiris JS, Guan Y (2005) Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol 43:5760-5767.
3. Capua I, Terregino C, Cattoli G, Mutinelli F, Rodriguez JF (2003) Development of a DIVA (differentiating infected from vaccinated animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza. Avian Pathol 32:47-55.
4. Capua I, Alexander DJ (2004) Avian influenza: recent developments. Avian Pathol 33:393-404.
5. Capua I, Terregino C, Cattoli G, Toffan A (2004) Increased resistance of vaccinated turkeys to experimental infection with an H7N3 low-pathogenicity avian influenza virus. Avian Pathol 33:158-163.
6. Capua I, Marangon S (2007) Control and prevention of avian influenza in an evolving scenario. Vaccine 25:5645-5652.
7. Chen H, Subbarao K, Swayne D, Chen Q, Lu X, Katz J, Cox N, Matsuoka Y (2003) Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate. Vaccine 21:1974-1979.
8. de Wit E, Munster VJ, Spronken MI, Bestebroer TM, Baas C, Beyer WE, Rimmelzwaan GF, Osterhaus AD, Fouchier RA (2005) Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. J Virol 79:12401-12407.
9. Ellis TM, Leung CY, Chow MK, Bissett LA, Wong W, Guan Y, Malik Peiris JS (2004) Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission. Avian Pathol 33:405-412.
10. Guan Y, Shortridge KF, Krauss S, Webster RG (1999) Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? Proc Natl Acad Sci USA 96:9363-9367.
11. Guan Y, Shortridge KF, Krauss S, Chin PS, Dyrting KC, Ellis TM, Webster RG, Peiris M (2000) H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China. J Virol 74:9372-9380.
12. Guo Y, Li J, Cheng X, Wang M, Zhou Y, Li C, Cai F, Liao H, Zhang Y, Guo J, Huang R, Bei D (1999) Discovery of men infected by avian influenza A (H9N2) virus. Chin J Exp Clin Virol 13:105-108.
13. Guo Y, Xie J, Wang M, Dong J, Guo J, Zhang Y, Wu K (2000) A strain of influenza A H9N2 virus repeatedly isolated from human population in China. Chin J Exp Clin Virol 14:209-212.
14. Halvorson DA (2002) The control of H5 or H7 mildly pathogenic avian influenza: a role for inactivated vaccine. Avian Pathol 31:5-12.
15. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG (2000) A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 97:6108-6113.
16. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146:2275-2289.
17. Homme PJ, Easterday BC (1970) Avian influenza virus infections. I. Characteristics of influenza A-turkey-Wisconsin-1966 virus. Avian Dis 14:66-74.
18. Lee CW, Senne DA, Suarez DL (2004) Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (differentiating infected from vaccinated animals) strategy for the control of avian influenza. Vaccine 22:3175-3181.
19. Li KS, Xu KM, Peiris JS, Poon LL, Yu KZ, Yuen KY, Shortridge KF, Webster RG, Guan Y (2003) Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? J Virol 77:6988-6994.
20. Liu M, Wood JM, Ellis T, Krauss S, Seiler P, Johnson C, Hoffmann E, Humberd J, Hulse D, Zhang Y, Webster RG, Perez DR (2003) Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics. Virology 314:580-590.
21. Lu X, Renshaw M, Tumpey TM, Kelly GD, Hu-Primmer J, Katz JM (2001) Immunity to influenza A H9N2 viruses induced by infection and vaccination. J Virol 75:4896-4901.
22. Middleton D, Bingham J, Selleck P, Lowther S, Gleeson L, Lehrbach P, Robinson S, Rodenberg J, Kumar M, Andrew M (2007) Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks. Virology 359:66-71.
23. Naeem K, Naurin M, Rashid S, Bano S (2003) Seroprevalence of avian influenza virus and its relationship with increased mortality and decreased egg production. Avian Pathol 32:285-289.
24. Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, Gao P, Hughes M, Perez DR, Donis R, Hoffmann E, Hobom G, Kawaoka Y (1999) Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci USA 96:9345-9350.
25. Peiris M, Yuen KY, Leung CW, Chan KH, Ip PL, Lai RW, Orr WK, Shortridge KF (1999) Human infection with influenza H9N2. Lancet 354:916-917.
26. Phelan MA, Mayner RE, Bucker DJ, Ennis FA (1980) Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents. J Biol Stand 8:233-242.
27. Qiu M, Fang F, Chen Y, Wang H, Chen Q, Chang H, Wang F, Wang H, Zhang R, Chen Z (2006) Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice. Biochem Biophys Res Commun 343:1124-1131.
28. Reed LJ, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27:493-497.
29. Saito T, Lim W, Suzuki T, Suzuki Y, Kida H, Nishimura SI, Tashiro M (2001) Characterization of a human H9N2 influenza virus isolated in Hong Kong. Vaccine 20:125-133.
30. Suarez DL (2005) Overview of avian influenza DIVA test strategies. Biologicals 33:221-226.
31. Webster RG, Webby RJ, Hoffmann E, Rodenberg J, Kumar M, Chu HJ, Seiler P, Krauss S, Songserm T (2006) The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens. Virology 351:303-311.
32. Wu R, Zhang H, Yang K, Liang W, Xiong Z, Liu Z, Yang X, Shao H, Zheng X, Chen M, Xu D (2009) Multiple amino acid substitutions are involved in the adaptation of H9N2 avian influenza virus to mice. Vet Microbiol 138:85-91.